Drug Database
Back to search

Netherlands· NL-a315d4f25acf

Dectova 10 mg/ml, oplossing voor infusie

A zanamivir product containing zanamivir x-water, registered in Netherlands by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 15 of our 19 countries.

ATC J05AH01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDectova 10 mg/ml, oplossing voor infu…ATCJ05AH01REGISTER NO.NL-a315d4f25acfPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zanamivir x-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zanamivir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AH01 (zanamivir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search zanamivir products by name

Zanamivir · ATC J05AH01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZANAMIVIR X-WATER
Manufacturer
GlaxoSmithKline Trading Services Limited
Country
Netherlands (NL)
ATC code
J05AH01
ATC class
Zanamivir
Defined daily dose
20 mg, Inhal
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/18/1349

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

13 interactions on record for zanamivir.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zanamivir against other medicinesHow interaction checks work

Zanamivir · interactions on record

13 records

  • 5 moderate
  • 8 info

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zanamivir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zanamivir products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Relenza Rotadisks
  • Belgium · Relenza
  • Bulgaria · Реленца
  • Germany · Relenza
  • Denmark · Relenza
  • Spain · Relenza
  • Finland · Relenza
  • France · Relenza
  • United Kingdom (Northern Ireland) · Relenza
  • Croatia · Relenza
  • Ireland · Relenza
  • Iceland · Dectova, Relenza
  • Italy · Relenza
  • Liechtenstein · Dectova
  • Luxembourg · Relenza
  • Norway · Dectova, Relenza
  • Poland · Relenza
  • Portugal · Relenza
  • Sweden · Relenza
  • Slovenia · Relenza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c9a8985-930e-415c-9d27-4c0f44a177ac
GET /v1/drugs/3c9a8985-930e-415c-9d27-4c0f44a177ac?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/dectova-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Zanamivir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp122264",
  "excipients": [
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ZANAMIVIR X-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/04/26",
  "procedure_number": "EMEA/H/C/004102",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/18/1349",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about zanamivir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console